Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01422538 · ClinicalTrials.gov registry record · NA
Ultherapy™ Treatment Following Sculptra® Treatment
A NA study, sponsored by Ulthera.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT01422538: Completed NA study, sponsored by Ulthera.
NCT01422538 is a NA study that has completed, run by Ulthera. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01422538, a NA study, has completed, sponsored by Ulthera.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This clinical trial will evaluate clinical outcomes associated with the non-invasive Ultherapy™ treatment to improve skin laxity and tightening following a Sculptra® treatment.
Primary Outcome
Three masked assessors reviewed pre- and 90 days post-treatment photos from 29 subjects who returned for their 90-day follow-up visit, assessing for improvement in skin laxity at 90 days post-treatment compared to baseline, i.e., lifted and tightened skin in the areas treated with the assigned study treatment based on the assigned study arm.
Interventions
- DEVICE Ulthera® System
- DRUG Sculptra®
- OTHER Sculptra® treatment followed by Ultherapy™ treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-09 |
| Phase | NA |
What the finished NCT01422538 record still lists
NCT01422538 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Ulthera® System is the first listed.
NCT01422538 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01422538 about?
NCT01422538 is a clinical study titled "Ultherapy™ Treatment Following Sculptra® Treatment". This clinical trial will evaluate clinical outcomes associated with the non-invasive Ultherapy™ treatment to improve skin laxity and tightening following a Sculptra® treatment.
What is the current status of trial NCT01422538?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2011-05. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01422538?
The interventions under investigation include: Ulthera® System (DEVICE), Sculptra® (DRUG), Sculptra® treatment followed by Ultherapy™ treatment (OTHER).
Who is sponsoring clinical trial NCT01422538?
This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01422538's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia